Will Retatrutide (new obesity drug) be FDA approved by the end of 2024?
6
130Ṁ456resolved Jan 1
Resolved
NO1D
1W
1M
ALL
This question is managed and resolved by Manifold.
Get
1,000 to start trading!
1,000🏅 Top traders
| # | Name | Total profit |
|---|---|---|
| 1 | Ṁ38 | |
| 2 | Ṁ14 | |
| 3 | Ṁ14 | |
| 4 | Ṁ10 |
Sort by:
Phase 3 trial is estimated to complete in late 2025: https://classic.clinicaltrials.gov/ct2/show/NCT05882045
Related questions
Related questions
Will semaglutide be taken off FDA's drug shortage list in 2025?
97% chance
Will Retatrutide (new obesity drug) be FDA approved by the end of 2025?
36% chance
Will Retatrutide (new obesity drug) be FDA approved by the end of 2026?
85% chance
Will an AI-designed drug get FDA approval by the end of 2025?
21% chance
Will Ozempic be FDA approved for use in type 1 diabetes patients by end of 2024?
7% chance
Will a drug to be used by most healthy adults be approved by 2043 year end?
70% chance
Will a drug that didn't go through human clinical trials be approved by 2034?
29% chance
Will Pfizer announce a weight loss drug competing with Ozempic and Wygovy before 12/31/2024?
35% chance
Will a GLP-1 agonist diabetes / weight loss drug be the top bestselling drug in 2025?
30% chance
Will any new drug be approved for treating Long COVID or ME/CFSby the end of 2024?
4% chance